Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease.
暂无分享,去创建一个
[1] A. Zeiher. Endothelial vasodilator dysfunction: Pathogenetic link to myocardial ischaemia or epiphenomenon? , 1996, The Lancet.
[2] V. Fuster,et al. The pathogenesis of coronary artery disease and the acute coronary syndromes (2). , 1992, The New England journal of medicine.
[3] A. Zeiher,et al. Impaired endothelium-dependent vasodilation of coronary resistance vessels is associated with exercise-induced myocardial ischemia. , 1995, Circulation.
[4] D. Harrison,et al. Hypercholesterolemia increases endothelial superoxide anion production. , 1993, The Journal of clinical investigation.
[5] R. Virmani,et al. Interaction of genetic deficiency of endothelial nitric oxide, gender, and pregnancy in vascular response to injury in mice. , 1998, The Journal of clinical investigation.
[6] J. Morrow,et al. Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. , 1995, The New England journal of medicine.
[7] M. Corretti,et al. Estrogens, progestins, and heart disease: can endothelial function divine the benefit? , 1998, Circulation.
[8] S. Kaul,et al. Functional improvement precedes structural regression of atherosclerosis. , 1994, Circulation.
[9] R. Cohen,et al. Endothelium-dependent hyperpolarization. Beyond nitric oxide and cyclic GMP. , 1995, Circulation.
[10] A. Zeiher,et al. A positive family history of premature coronary artery disease is associated with impaired endothelium-dependent coronary blood flow regulation. , 1999, Circulation.
[11] R. Busse,et al. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation , 1999, Nature.
[12] U. Förstermann,et al. Selective Attenuation of Endothelium‐Mediated Vasodilation in Atherosclerotic Human Coronary Arteries , 1988, Circulation research.
[13] V. Fuster,et al. The pathogenesis of coronary artery disease and the acute coronary syndromes (1). , 1992, The New England journal of medicine.
[14] A. Tajik,et al. Epicardial vasomotor responses to acetylcholine are not predicted by coronary atherosclerosis as assessed by intracoronary ultrasound. , 1995, Journal of the American College of Cardiology.
[15] P. Ganz,et al. Atherosclerosis impairs flow-mediated dilation of coronary arteries in humans. , 1989, Circulation.
[16] A. Zeiher,et al. Quantitative assessment of coronary vasoreactivity in humans in vivo. Importance of baseline vasomotor tone in atherosclerosis. , 1995, Circulation.
[17] E. Nabel,et al. Dilation of normal and constriction of atherosclerotic coronary arteries caused by the cold pressor test. , 1988, Circulation.
[18] H. Drexler,et al. Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis. , 1991, Circulation.
[19] S. Higano,et al. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. , 2000, Circulation.
[20] W. Weintraub,et al. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. , 1995, The New England journal of medicine.
[21] P. Ganz,et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. , 1986, The New England journal of medicine.
[22] J. Vane,et al. Regulatory functions of the vascular endothelium. , 1990, The New England journal of medicine.
[23] A. Yeung,et al. The effect of atherosclerosis on the vasomotor response of coronary arteries to mental stress. , 1991, The New England journal of medicine.
[24] H. Drexler,et al. Coronary vasomotion in response to sympathetic stimulation in humans: importance of the functional integrity of the endothelium. , 1989, Journal of the American College of Cardiology.
[25] M. Büchi,et al. Effects of calcium antagonism and HMG-coenzyme reductase inhibition on endothelial function and atherosclerosis : rationale and outline of the ENCORE trials , 1999 .
[26] N. Flavahan. Atherosclerosis or lipoprotein-induced endothelial dysfunction. Potential mechanisms underlying reduction in EDRF/nitric oxide activity. , 1992, Circulation.
[27] Alexander Rw. Atherosclerosis as disease of redox-sensitive genes. , 1998 .
[28] J. Deanfield,et al. Smooth muscle dysfunction occurs independently of impaired endothelium-dependent dilation in adults at risk of atherosclerosis. , 1998, Journal of the American College of Cardiology.
[29] A. Yeung,et al. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. , 1995, The New England journal of medicine.
[30] A. Yeung,et al. Role of impaired endothelium-dependent vasodilation in ischemic manifestations of coronary artery disease , 1993 .
[31] S Moncada,et al. Regulation of Vascular Homeostasis by Nitric Oxide , 1993, Thrombosis and Haemostasis.
[32] E. Nabel,et al. Atherosclerosis influences the vasomotor response of epicardial coronary arteries to exercise. , 1989, The Journal of clinical investigation.
[33] V. Fuster,et al. Coronary artery disease: pathogenesis and acute coronary syndromes. , 2001, The Mount Sinai journal of medicine, New York.
[34] D. Harrison,et al. Cellular and molecular mechanisms of endothelial cell dysfunction. , 1997, The Journal of clinical investigation.
[35] A. Quyyumi,et al. Nitric oxide activity in the human coronary circulation. Impact of risk factors for coronary atherosclerosis. , 1995, The Journal of clinical investigation.
[36] P. Tsao,et al. Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit. , 1992, The Journal of clinical investigation.
[37] J. Keaney,et al. Antioxidants and atherosclerotic heart disease. , 1997, The New England journal of medicine.
[38] A. Zeiher,et al. Long-term cigarette smoking impairs endothelium-dependent coronary arterial vasodilator function. , 1995, Circulation.
[39] A. Yeung,et al. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. , 1990, Circulation.